Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 151-175/1697

Authors: Leung, WK Chow, TP Ng, EKW Chan, FKL Chung, SCS Sung, JJY
Citation: Wk. Leung et al., Validation of a new immunoblot assay for the diagnosis of Helicobacter pylori in the Asian population, ALIM PHARM, 15(3), 2001, pp. 423-428

Authors: Stanghellini, V
Citation: V. Stanghellini, Pain versus discomfort - is differentiation clinically useful?, ALIM PHARM, 15(2), 2001, pp. 145-149

Authors: Avidan, B Sonnenberg, A Schnell, TG Sontag, SJ
Citation: B. Avidan et al., Walking and chewing reduce postprandial acid reflux, ALIM PHARM, 15(2), 2001, pp. 151-155

Authors: Bortolotti, M Mari, C Lopilato, C La Rovere, L Miglioli, M
Citation: M. Bortolotti et al., Sildenafil inhibits gastroduodenal motility, ALIM PHARM, 15(2), 2001, pp. 157-161

Authors: Armuzzi, A Cremonini, F Bartolozzi, F Canducci, F Candelli, M Ojetti, V Cammarota, G Anti, M De Lorenzo, A Pola, P Gasbarrini, G Gasbarrini, A
Citation: A. Armuzzi et al., The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy, ALIM PHARM, 15(2), 2001, pp. 163-169

Authors: Dormann, H Krebs, S Muth-Selbach, U Criegee-Rieck, M Radespiel-Troger, M Levy, M Hahn, EG Brune, K Schneider, HT
Citation: H. Dormann et al., Adverse drug reactions in patients with gastroenterological diseases: doesage increase the risk?, ALIM PHARM, 15(2), 2001, pp. 171-180

Authors: Moschetta, A Stolk, MFJ Rehfeld, JF Portincasa, P Slee, PHTJ Koppeschaar, HPF Van Erpecum, KJ Vanberge-Henegouwen, GP
Citation: A. Moschetta et al., Severe impairment of postprandial cholecystokinin release and gall-bladderemptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR, ALIM PHARM, 15(2), 2001, pp. 181-185

Authors: Chan, FKL To, KF Ng, YP Lee, TL Cheng, ASL Leung, WK Sung, JJY
Citation: Fkl. Chan et al., Expression and cellular localization of COX-1 and-2 in Helicobacter pylorigastritis, ALIM PHARM, 15(2), 2001, pp. 187-193

Authors: Hsu, PI Lai, KH Tseng, HH Lo, GH Lo, CC Lin, CK Cheng, JS Chan, HH Ku, MK Peng, NJ Chien, EJ Chen, W Hsu, PN
Citation: Pi. Hsu et al., Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia, ALIM PHARM, 15(2), 2001, pp. 195-201

Authors: Oderda, G Rapa, A Marinello, D Ronchi, B Zavallone, A
Citation: G. Oderda et al., Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children, ALIM PHARM, 15(2), 2001, pp. 203-206

Authors: Talley, NJ Verlinden, M Jones, M
Citation: Nj. Talley et al., Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form, ALIM PHARM, 15(2), 2001, pp. 207-216

Authors: Mulcahy, HE Hennessy, E Connor, P Rhodes, B Patchett, SE Farthing, MJG Fairclough, PD
Citation: He. Mulcahy et al., Changing patterns of sedation use for routine out-patient diagnostic gastroscopy between 1989 and 1998, ALIM PHARM, 15(2), 2001, pp. 217-220

Authors: Todd, JA Weston, T Macdonald, TM Johnston, DA Dillon, JF
Citation: Ja. Todd et al., The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis, ALIM PHARM, 15(2), 2001, pp. 221-226

Authors: Sharma, VK Leontiadis, GI Howden, CW
Citation: Vk. Sharma et al., Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis, ALIM PHARM, 15(2), 2001, pp. 227-231

Authors: Pehl, C Pfeiffer, A Waizenhoefer, A Wendl, B Schepp, W
Citation: C. Pehl et al., Effect of caloric density of a meal on lower oesophageal sphincter motility and gastro-oesophageal reflux in healthy subjects, ALIM PHARM, 15(2), 2001, pp. 233-239

Authors: Calleja, JL Albillos, A Rossi, I Moreno, R Domper, F Marinez, JL Escartin, P
Citation: Jl. Calleja et al., Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response, ALIM PHARM, 15(2), 2001, pp. 241-249

Authors: Vecchi, M Meucci, G Gionchetti, P Beltrami, M Di Maurizio, P Beretta, L Ganio, E Usai, P Campieri, M Fornaciari, G De Franchis, R
Citation: M. Vecchi et al., Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study, ALIM PHARM, 15(2), 2001, pp. 251-256

Authors: Mizoguchi, H Hase, S Tanaka, A Takeuchi, K
Citation: H. Mizoguchi et al., Lack of small intestinal ulcerogenecity of nitric oxide-releasing indomethacin, NCX-530, in rats, ALIM PHARM, 15(2), 2001, pp. 257-267

Authors: Freston, J
Citation: J. Freston, Acid-related disorders in an era of changing Helicobacter pylori prevalence - Foreword, ALIM PHARM, 15, 2001, pp. 1-1

Authors: Freston, JW
Citation: Jw. Freston, Review article: role of proton pump inhibitors in non-H. pylori-related ulcers, ALIM PHARM, 15, 2001, pp. 2-5

Authors: Tytgat, GNJ
Citation: Gnj. Tytgat, Review article: long-term use of proton pump inhibitors in GORD - help or hindrance?, ALIM PHARM, 15, 2001, pp. 6-9

Authors: McColl, KEL
Citation: Kel. Mccoll, Review article: tackling the 'dyspeptic problem', ALIM PHARM, 15, 2001, pp. 10-13

Authors: Malfertheiner, P Stanghellini, V Galmiche, JP Jones, RH
Citation: P. Malfertheiner et al., Review article: managing the dyspeptic patient - an interactive discussion, ALIM PHARM, 15, 2001, pp. 14-19

Authors: Nielsen, OH Vainer, B Rask-Madsen, J
Citation: Oh. Nielsen et al., Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine, ALIM PHARM, 15(11), 2001, pp. 1699-1708

Authors: Lindsay, JO Hodgson, HJF
Citation: Jo. Lindsay et Hjf. Hodgson, Review article: the immunoregulatory cytokine interleukin-10 - a therapy for Crohn's disease?, ALIM PHARM, 15(11), 2001, pp. 1709-1716
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>